The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications.
Academic Article
Publication Date:
2011
Short description:
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications / Podar, K., Zimmerhackl, A., Fulciniti, M., Tonon, G., Hainz, U., Tai, Y.t., Vallet, S., Halama, N., Jäger, D., Olson, D.l., Sattler, M., Chauhan, D., Anderson, Kc.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - 155:(2011), pp. 438-448. [10.1111/j.1365-2141.2011.08864.x]
Iris type:
1.1 Articolo in rivista
List of contributors:
Podar, K; Zimmerhackl, A; Fulciniti, M; Tonon, G; Hainz, U; Tai, Yt; Vallet, S; Halama, N; Jäger, D; Olson, Dl; Sattler, M; Chauhan, D; Anderson, Kc.
Published in: